Clinical Trial Update: Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures [Phase 4]

View source ↗

Summary

Phase 4 trial in children with partial seizures assessed the efficacy, safety, and tolerability of oxcarbazepine monotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)
• TRILEPTAL (OXCARBAZEPINE)

Snippet

Sponsor: Novartis | Conditions: Epilepsy, Partial Seizures | Phase 4 | Status: COMPLETED